Related references
Note: Only part of the references are listed.Relationship between age and platelet activation in patients with stable and unstable angina
John R. Gilstad et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2009)
Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome
Umesh U. Tamhane et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor κB-dependent inflammation in monocytes
Roland Schmidt et al.
CIRCULATION RESEARCH (2008)
Platelet activation in acute pulmonary embolism
T. Chung et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Elevated levels of platelet-monocyte aggregates and related circulating biomarkers in patients with acute coronary syndrome
Junhong Wang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells -: Implications in acute myocardial infarction
R Schmidt et al.
CIRCULATION (2006)
Platelets in atherothrombosis
DA Vorchheimer et al.
MAYO CLINIC PROCEEDINGS (2006)
Tumor necrosis factor-α as trigger of platelet activation in patients with heart failure
P Pignatelli et al.
BLOOD (2005)
Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation
KT Tan et al.
PLATELETS (2005)
Elevated circulating levels of matrix metalloproteinase-9 and-2 in patients with symptomatic coronary artery disease
B Zeng et al.
INTERNAL MEDICINE JOURNAL (2005)
Platelet-monocyte aggregates predict troponin rise after percutaneous coronary intervention and are inhibited by Abciximab
MJ Ray et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2005)
Regulation of CD147 cell surface expression - Involvement of the proline residue in the CD147 transmembrane domain
V Yurchenko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Acetylsalicylic acid, diclofenac, and lornoxicam, but not rofecoxib, affect platelet CD 62 expression
AM Blaicher et al.
ANESTHESIA AND ANALGESIA (2004)
Oxidized low-density lipoproteins stimulate extracellular matrix metalloproteinase inducer (EMMPRIN) release by coronary smooth muscle cells
C Haug et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Circulating matrix metalloproteinase-1 and-3 in patients with an acute coronary syndrome
T Inoue et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets
ME McKenzie et al.
BLOOD COAGULATION & FIBRINOLYSIS (2003)
Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease
U Klinkhardt et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry
NL Li et al.
THROMBOSIS RESEARCH (2003)
Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma
TC Major et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
C-reactive protein and angiographic coronary artery disease: Independent and additive predictors of risk in subjects with angina
JS Zebrack et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets
CD Garlichs et al.
HEART (2001)
Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis
JE Joseph et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction
MI Furman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers
AA Weber et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Share Paper
